Patent Law Weblog
recent posts
- USPTO and DOJ Statement of Interest in Collision Communications: Another Thumb on the Scale in Favor of NPE Patent Plaintiffs
- Oasis Tooling, Inc. v. Siemens Industry Software Inc. (Fed. Cir. 2026)
- Why AI Will Not Take Over the World
- BioNTech Sues Moderna over mRNA Vaccine Technology
- CNIPA Issues Letter on Identity of Foreign Inventors
about
Month: July 2011
-
The SMi Group will be holding its 2nd conference on Biosimilars and Biobetters from September 26-27, 2011 in London, UK. The conference will offer presentations on the following topics: • The market for biosimilars: Unraveling the mystery;• The EMA scientific advice compared with EMA guidelines;• Industry interpretation the new guideline on biosimilar mAbs;• Next generation…
-
The Intellectual Property Institute of Canada (IPIC) will be holding its 85th Annual Meeting on September 14-16, 2011 in Chicago, IL. Among the presentations being offered at the annual meeting are: • Canada's Global Perspective on SR&ED (Scientific Research & Experimental Development) — pre-conference workshop;• Building a 21st Century Patent System in the Digital Age…
-
IBC Legal Conferences will be holding its 8th Annual Pharmaceutical Law Academy on September 6-7, 2011 in London, UK. IBC Legal faculty will offer presentations on the following topics: • Clinical trials;• Legal aspects of paediatric medicines regulation;• EU vertical and horizontal block exemption regulations — Implications for the pharmaceutical industry;• Generics and biosimilars —…
-
By Andrew Williams — On June 29, a panel at the 2011 BIO International Conference discussed the topic of "IP Challenges for Personalized Medicine: Navigating Bilski, Myriad, and Prometheus." This session addressed one of the most prevalent issues at this year's conference — are the courts going to alter the intellectual property landscape for biomarkers…
-
By James DeGiulio — Elan and Abbott Drop Tricor Patent Suit with Teva Elan and exclusive licensee Abbott have agreed to dismiss their case with Teva over its intended marketing of a generic version of the cholesterol drug Tricor. The dispute between the companies began in July 2010, when Abbott, subsidiary Fournier, and Elan brought…
-
By Donald Zuhn — The U.S. Patent and Trademark Office recently announced the expansion or implementation of Patent Prosecution Highway (PPH) pilot programs with the Korean Intellectual Property Office (KIPO), Swedish Patent and Registration Office (PRV), Nordic Patent Institute (NPI), and Israel Patent Office (ILPO). With the addition of these new pilot programs, the USPTO…
-
By Kevin E. Noonan — Steve Burrill, President and CEO of Burrill & Co. took the stage at BIO 2011 in Washington, D.C. last Tuesday, and spent his 90 minutes in a brief retrospective of his 25 years in the biotechnology industry as well as his impressions and opinions on the current state of that…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Endo Pharmaceuticals Inc. v. Watson Laboratories Inc. et al.1:11-cv-00575; filed June 29, 2011 in the District Court of Delaware • Plaintiff: Endo Pharmaceuticals Inc.• Defendants: Watson Laboratories Inc.; Watson Pharmaceuticals Inc.; Watson Pharma Inc. Infringement…
-
July 7, 2011 – Inequitable Conduct after Therasense (Intellectual Property Owners Association) – 2:00 PM (ET) July 8, 2011 – Stanford v. Roche: The Impact on Management of University IP (Technology Transfer Tactics) – 1:00 – 2:00 PM (Eastern) July 16-19, 2011 – 2011 Annual Meeting; The Nuts & Bolts of Patent Prosecution Practice; and…
-
American Conference Institute (ACI) will be holding the Boston edition of its FDA Boot Camp conference on September 22-23, 2011 in Boston, MA. ACI faculty will help attendees: • Master the basics of the application and approval processes for drugs, biologics, and devices;• Comprehend the structure of the FDA and the roles of the three…
Patent Docs 